US OptionsDetailed Quotes
WW240705C1000
- 0.25
- +0.04+19.05%
15min DelayClose Jul 5 15:59 ET
0.25High0.20Low
0.20Open0.21Pre Close24 Volume70 Open Interest1.00Strike Price595.00Turnover0.00%IV-2.34%PremiumJul 5, 2024Expiry Date0.28Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.12Leverage Ratio--Theta--Rho--Eff Leverage--Vega
WW International Stock Discussion
Sign in to post a comment
No insider trading of WW International shares in the last quarter and low insider ownership compared to others leaves an unenthusiastic impression. Investors should note 3 warning signs for WW International.
2
Debbane's exit and Invus' stake sale in WW International seems well-timed considering the company's stock decline. The company's venture into remote prescription of weight-loss drugs via Sequence acquisition hasn't convinced investors of its resilience against GLP-1 drugs pressure.
1
The company's transition from self-restraint to medication for weight loss is seen as a necessary evolution, but the competitive landscape and supply constraints for GLP-1 drugs could pose challenges. As Oprah exits the stock, investors are advised to exercise caution.
Oprah Winfrey's departure has negatively impacted investor sentiment, causing a sharp drop in the company's stock. Her exit could potentially affect the company's future performance.
Winfrey's departure from the board and her decision to donate her shares could potentially impact the company's stock performance. The rising popularity of weight-loss drugs presents both opportunities and challenges for Weight Watchers and other companies in the industry.
The company's revenue and digital subscribers have been declining over the last five years. The cash profitability has been mediocre and Q4 results were disappointing, falling short of Wall Street's expectations. The company's stock is down 22.8% on the results.
ColumnsOptions Market Statistics: Nvidia's Q4 Earnings Soar Beyond Forecasts, Fueled by Surging AI Demand
News Highlights
$NVIDIA(NVDA.US$ shares fell by 2.85%, closing at $674.72. Its options trading volume is 1.55 million. Call contracts account for 60.9% of the total trading volume. The most traded calls are contracts of $1300 strike price that expire on Feb 23rd. The total volume reaches 56,084 with an open interest of 16,391. The most traded puts are contracts of a $600 strike price that expires o...
$NVIDIA(NVDA.US$ shares fell by 2.85%, closing at $674.72. Its options trading volume is 1.55 million. Call contracts account for 60.9% of the total trading volume. The most traded calls are contracts of $1300 strike price that expire on Feb 23rd. The total volume reaches 56,084 with an open interest of 16,391. The most traded puts are contracts of a $600 strike price that expires o...
21
1
Weight Watchers' stock suffers due to a controversial marketing campaign and increased competition. The acquisition of Sequence failed to sustain initial stock gains, hinting at strategic challenges.
WW International's low P/S ratio indicates investor anticipation of restricted future growth due to poor revenue outlook, keeping its stock price's valuation low.
No comment yet
ShroomieOP : looks like new historical lows
ShroomieOP : boom